article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. However, a result can be statistically significant but not clinically significant–meaning that even though a study may detect a difference on paper, it may make no tangible difference in real-world application.

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” In 2019, Dr. Johnson received the R. ” About Ehave, Inc. Ehave, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients. Since 2009, Dr. Fisher-Corn has served as Editor-in-Chief of TheAnswerPage.com.

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies. Topical cannabis products can also be useful, but research and data is very limited.

Terpenes 132
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. The Stanleys told me their wait-list peaked at 15,000 names.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. The coding method was a combination of deductive and inductive codes.